Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Functional Rac-1 and Nck signaling networks are required for FGF-2-induced DNA synthesis in MCF-7 cells

Abstract

The effects of Fibroblast Growth Factor-2 (FGF-2) on breast cancer cell DNA synthesis are controversial. To elucidate the mechanisms by which FGF-2 stimulates or inhibits DNA synthesis, we analysed FGF-2 signaling pathways in breast cancer MCF-7 and MCF-7 cells overexpressing Ha-Ras (MCF-7ras). We found that FGF-2-induction of DNA synthesis correlates with Ras transient activation, FRS-2 tyrosine phosphorylation and low level of expression of p66Shc. In addition, Nck-associated proteins are highly tyrosine phosphorylated and JNK reaches a higher level of activation when FGF-2 triggers DNA synthesis. Interestingly upon FGF-2 treatment, JNK activation and DNA synthesis are dependent on Rac-1 activity. These results confirm that in MCF-7 cells, induction of DNA synthesis by FGF-2 requires a transient activation of the Ras/MAPK cascade and demonstrates for the first time that intact Rac-1 and Nck signaling networks are required.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Alblas J, Slager-Davidov R, Steenbergh PH, Sussenbach JS and van der Burg B. . 1998 Oncogene 16: 131–139.

  • Bikfalvi A, Klein S, Pintucci G and Rifkin DB. . 1997 Endocrine Rev. 18: 26–45.

  • Blaikie P, Immanuel D, Wu J, Li N, Yajnick V and Margolis B. . 1994 J. Biol. Chem. 269: 32031–32034.

  • Cantrell D. . 1998 Trends Cell Biol. 8: 180–182.

  • Di Guglielmo GM, Baass PC, Ou W-J, Posner BI and Bergeron JJM. . 1994 EMBO J. 13: 4269–4277.

  • Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z and Yaholom J. . 1997 Clin. Cancer Res. 3: 135–142.

  • Gelmann EP, Thompson EW and Sommers CL. . 1992 Int. J. Cancer 50: 665–669.

  • Goh KC, Lim YP, Ong SH, Siak CB, Cao X, Tan YH and Guy GR. . 1996 J. Biol. Chem. 271: 5832–5838.

  • Gomm J, Smith J, Ryall G, Baillie R, Turnbull L and Coombes C. . 1991 Cancer Res. 51: 4685–4692.

  • Hadari YR, Kouhara H, Lax I and Schlessinger J. . 1998 Mol. Cell. Biol. 18: 3966–3973.

  • Jaye M, Howk R, Burgess W, Ricca GA, Chiu I-M, Ravera MW, O'Brien SJ, Modi WS, Maciag T and Drohan WN. . 1986 Science 233: 541–545.

  • Kanai M, Göke M, Tsunekawa S and Podolsky DK. . 1997 J. Biol. Chem. 272: 6621–6628.

  • Karey KP and Sirbasku DA. . 1988 Cancer Res. 48: 4083–4092.

  • Kavanaugh DE and Williams LT. . 1994 Science 266: 1862–1865.

  • Kerkhoff E, Houben R, Löffler S, Troppmair J, Lee J-E and Rapp UR. . 1998 Oncogene 16: 211–216.

  • Klint P, Kanda S and Claesson-Welsh L. . 1995 J. Biol. Chem. 270: 23337–23344.

  • Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I and Schlessinger J. . 1997 Cell 89: 693–702.

  • Laemmli UK. . 1970 Nature 227: 680–685.

  • Liu J-F, Issad T, Chevet E, Ledoux D, Courty J, Caruelle J-P, Barritault D, Crepin M and Bertin B. . 1998 Eur. J. Biochem. 258: 271–276.

  • Marais R, Light Y, Patterson HF and Marshall CJ. . 1995 EMBO J. 14: 3136–3145.

  • McLeskey SW, Ding IY, Lippman ME and Kern FG. . 1994 Cancer Res. 54: 523–530.

  • Medema RH, De Vries-Smits AMM, Van Der Zon GCM, Maasen JA and Bos JL. . 1993 Mol. Cell. Biol. 13: 155–162.

  • Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G, Pawson T, Di Fiore PP, Lanfrancone L and Pelicci PG. . 1997 EMBO J. 16: 706–716.

  • Miyamoto M, Naruo K-I, Seko C, Matsumoto S, Kondo T and Kurokawa T. . 1993 Mol. Cell. Biol. 13: 4251–4259.

  • Mohammadi M, Schlessinger J and Hubbard SR. . 1996a Cell 86: 577–580.

  • Mohammadi M, Dikic I, Sorokin A, Burgess WH, Jaye M and Schlessinger J. . 1996b Mol. Cell. Biol. 16: 977–989.

  • Ohbayashi N, Hoshikawa M, Kimura S, Yamasaki M, Fukui S and Itoh N. . 1998 J. Biol. Chem. 273: 18161–18164.

  • Okada S, Kao AW, Ceresa BP, Blaikie P, Margolis B and Pessin JE. . 1997 J. Biol. Chem. 272: 28042–28049.

  • Olson MF, Paterson HF and Marshall CJ. . 1998 Nature 394: 295–299.

  • Ong SH, Goh KC, Lim PY, Low BC, Klint P, Claesson-Welsh L, Cao X, Tan YH and Guy GR. . 1996 Biochem. Biophys. Res. Commun. 3: 1021–1026.

  • Ong SH, Lim YP, Low BC and Guy GR. . 1997 Biochem. Biophys. Res. Commun. 238: 261–266.

  • Qiu RG, Chen J, Kirn D, McCormick F and Symons M. . 1995 Nature 374: 457–459.

  • Rabin SJ, Cleghon V and Kaplan DR. . 1993 Mol. Cell. Biol. 13: 2203–2213.

  • Roche S, McGlade J, Jones M, Gish GD, Pawson T and Courtneidge SA. . 1996 EMBO J. 15: 4940–4948.

  • Rockow S, Tang J, Xiong W and Li W. . 1996 Oncogene 12: 2351–2359.

  • Rodrigues GA, Park M and Schlessinger J. . 1997 EMBO J. 16: 2634–2645.

  • Roof RW, Haskell MD, Dukes BD, Sherman N, Kinter M and Parsons SJ. . 1998 Mol. Cell. Biol. 18: 7052–7063.

  • Sommers CL, Papageorge A, Wilding G and Gelmann EP. . 1990 Cancer Res. 50: 67–71.

  • Stein E, Huynh-Do U, Lane AA, Ceretti DP and Daniel TO. . 1997 J. Biol. Chem. 273: 1303–1308.

  • Stewart AJ, Westley BR and May FEB. . 1992 Br. J. Cancer 66: 640–648.

  • Vainikka S, Joukov V, Wennström S, Bergman M, Pelicci PG and Alitalo K. . 1994 J. Biol. Chem. 269: 18320–18326.

  • Wang H, Rubin M, Fenig E, DeBlasio A, Mendelsohn J, Yaholom J and Wieder R. . 1997 Cancer Res. 57: 1750–1757.

  • Wang JK, Xu H, Li HC and Goldfarb M. . 1996 Oncogene 13: 721–729.

  • Yamasaki M, Miyake A, Tagashira S and Itoh N. . 1996 J. Biol. Chem. 271: 15918–15921.

  • Yayon A, Klagsbrun M, Esko J, Leder P and Ornitz D. . 1991 Cell 64: 841–848.

  • Yiangou C, Gomm J, Cooper RC, Law M, Luqmani YA, Shousha S, Coombes RC and Johnston CL. . 1997 Br. J. Cancer 75: 28–33.

  • Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP and Samelson LE. . 1998 Cell 92: 83–92.

Download references

Acknowledgements

The authors gratefully acknowledge Dr JJM Bergeron for his constant support during the course of this work, Dr MD Katinka for helpful suggestions, PH Cameron, Drs N Lamarche and S Palcy for comments on the manuscript. J-F Liu was funded by a fellowship from the Ligue Contre le Cancer and E Chevet was supported by a post-doctoral fellowship from the `Association pour la Recherche contre le Cancer'. This work was funded in part by grants from the Ministère de l'Education Nationale to D Barritault and from the Medical Research Council of Canada to L Larose.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, JF., Chevet, E., Kebache, S. et al. Functional Rac-1 and Nck signaling networks are required for FGF-2-induced DNA synthesis in MCF-7 cells. Oncogene 18, 6425–6433 (1999). https://doi.org/10.1038/sj.onc.1203027

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1203027

Keywords

This article is cited by

Search

Quick links